Janus Henderson Global Life Sciences Fund Class T (JAGLX): prezzo del fondo comune di investimento e notizie

Home pageJAGLX • Fondo comune

Janus Henderson Global Life Sciences Fund Class T

81,02 $

29 dic · USD · MUTF · Disclaimer

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

65,21 $

SHSAX0,31%

Franklin Biotechnology Discovery Fund Class A

166,88 $

FBDIX0,42%

Fidelity Select Health Care Portfolio

28,64 $

FSPHX0,56%

ProFunds Biotechnology UltraSector Fund Investor Class

68,81 $

BIPIX1,83%

Fidelity Advisor Biotechnology Fund - Class A

37,91 $

FBTAX0,86%

Vanguard Health Care Fund Admiral Shares

86,78 $

VGHAX0,36%

Janus Henderson Contrarian Fund Class D

27,11 $

JACNX0,99%

ProFunds UltraNASDAQ-100 Fund Investor Class

128,18 $

UOPIX0,98%

Rydex NASDAQ-100® 2x Strategy Fund Class C

459,77 $

RYCCX0,95%

Fidelity Advisor Blue Chip Growth Fund - Class A

267,76 $

FBCCX0,52%

Fondo comune

Chiusura precedente

81,02 $

Rendimento YTD

24,87%

Indice di spesa

0,92%

Categoria

Healthcare Sector Equity

Rating Morningstar

Patrimonio netto

1,32 Mld USD

Rendimento

0,17%

Comm. ent.

Data di creazione

31 dic 1998

Notizie del mercato finanziario

The Globe and Mail

1 giorno fa

Competition intensifies among stock trading platforms

MSN

12 ore fa

S&P/TSX composite down more than 75 points, while US stock markets also lower

OSPTX

0,32%

The Motley Fool Canada

8 ore fa

You’ll Thank Yourself in a Decade for Owning These Top TSX Dividend Stocks

Yahoo! Finance Canada

9 ore fa

Here’s What’s Driving the TSX’s Top-Performing Stocks

The Spec

15 ore fa

A.I.S. Resources TSXV Reinstatement to Trading

Precious metal prices send S&P/TSX composite lower, U.S. markets also decline

OSPTX

0,32%